drugset / Trial / NCT02716857
Efficacy and Safety of Egalet-002 in Patients With Moderate-to-Severe Chronic Low Back Pain
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to determine the analgesic efficacy of Egalet-002 twice daily (BID) in patients with moderate-to-severe chronic low back pain
Timeline
- Start
- 2016-03
- Primary completion
- 2017-08
- Completion
- 2017-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Oxycodone | Other / unclassified | — | — |
Indications
No indication recorded.